150 related articles for article (PubMed ID: 19544141)
1. Sustained response of primary cutaneous CD30 positive anaplastic large cell lymphoma to bexarotene and photopheresis.
Sheehy O; Catherwood M; Pettengell R; Morris TC
Leuk Lymphoma; 2009 Aug; 50(8):1389-91. PubMed ID: 19544141
[No Abstract] [Full Text] [Related]
2. [Primary cutaneous CD30+ large T-Cell lymphoma with lymph node and cerebral metastases].
Simal E; Hörndler C; Porta N; Baldellou R
Actas Dermosifiliogr; 2010 Nov; 101(9):810-2. PubMed ID: 21034717
[No Abstract] [Full Text] [Related]
3. Nasal-type NK/T-cell lymphoma successfully treated with ProMACE-CytaBOM therapy.
Isogai R; Kawada A; Hashimoto K; Aragane Y; Tezuka T; Maeda Y; Kanamaru A
Dermatology; 2004; 209(3):243-5. PubMed ID: 15459544
[No Abstract] [Full Text] [Related]
4. Selective IgM deficiency in CD30+ cutaneous lymphoproliferative disorder.
Saini S; Dettore AJ; Bhambhani KJ; Buck S; Poulik J; Savaşan S
J Pediatr Hematol Oncol; 2011 May; 33(4):e156-9. PubMed ID: 21516014
[TBL] [Abstract][Full Text] [Related]
5. [Systemic follicular lymphoma with cutaneous manifestations and exclusively cutaneous recurrence].
Palacios Abufón A; Acebo Mariñas E; Gardeazabal García J; García-Ruiz JC
Actas Dermosifiliogr; 2012 Apr; 103(3):253-5. PubMed ID: 22093542
[No Abstract] [Full Text] [Related]
6. Sarcomatoid Variant of Primary Cutaneous Anaplastic Large Cell Lymphoma.
Natsuaki Y; Muto I; Kawamura M; Saruta H; Teye K; Ohshima K; Nakama T; Ohata C
Am J Dermatopathol; 2019 Dec; 41(12):e164-e167. PubMed ID: 31268929
[TBL] [Abstract][Full Text] [Related]
7. CD8-positive primary cutaneous anaplastic large cell lymphoma presenting as multiple scrotal nodules and plaques.
Xu H; Qian J; Wei J; Zhao Y; Zhou C; Chen D; Zhang J
Eur J Dermatol; 2011; 21(4):609-10. PubMed ID: 21680287
[No Abstract] [Full Text] [Related]
8. Successful treatment for recurrence of primary cutaneous anaplastic large-cell lymphoma in elderly patient with etoposide, mitoxantrone, cyclophosphamide, vincristine, prednisolone and bleomycin (VNCOP-B) therapy.
Isogai R; Fukao M; Kawada A
J Dermatol; 2007 Aug; 34(8):556-60. PubMed ID: 17683387
[TBL] [Abstract][Full Text] [Related]
9. Bexarotene--an alternative therapy for progressive cutaneous T-cell lymphoma? First experiences.
Bohmeyer J; Stadler R; Kremer A; Nashan D; Muche M; Gellrich S; Luger T; Sterry W
J Dtsch Dermatol Ges; 2003 Oct; 1(10):785-9. PubMed ID: 16281814
[TBL] [Abstract][Full Text] [Related]
10. Differential diagnosis and treatment of primary, cutaneous, anaplastic large cell lymphoma: not always an easy task.
Diamantidis MD; Papadopoulos A; Kaiafa G; Ntaios G; Karayannopoulou G; Kostopoulos I; Girtovitis F; Saouli Z; Kontoninas Z; Raptis ID; Savopoulos C; Hatzitolios A
Int J Hematol; 2009 Sep; 90(2):226-229. PubMed ID: 19548068
[TBL] [Abstract][Full Text] [Related]
11. Primary cutaneous CD30 positive anaplastic large cell lymphoma--report of a case treated with bexarotene.
Oliveira A; Fernandes I; Alves R; Lima M; Selores M
Leuk Res; 2011 Nov; 35(11):e190-2. PubMed ID: 21764128
[No Abstract] [Full Text] [Related]
12. A rare case of ALK negative CD30+ primary cutaneous anaplastic large cell lymphoma in a young adult.
Sridevi HB; Shanthala PR; Raghuveer CV; Prabhu AK; Akbar JK; Shivaprasad GS; Suresh PK; Navani S
J Cancer Res Ther; 2015; 11(3):656. PubMed ID: 26458652
[TBL] [Abstract][Full Text] [Related]
13. Non-Hodgkin's lymphoma and acquired immune deficiency syndrome (AIDS). A case report.
Plemons JM; Benton E; Rankin KV
Tex Dent J; 2005 Jul; 122(7):658-64. PubMed ID: 16152890
[No Abstract] [Full Text] [Related]
14. Cutaneous involvement in systemic anaplastic large cell lymphoma.
Kwok C; Salmo E
J Dtsch Dermatol Ges; 2015 Jul; 13(7):693-5. PubMed ID: 26031654
[No Abstract] [Full Text] [Related]
15. Autologous peripheral blood stem cell transplantation to treat CHOP-refractory aggressive subcutaneous panniculitis-like T cell lymphoma.
Nakahashi H; Tsukamoto N; Yamane A; Saitoh T; Uchiumi H; Handa H; Karasawa M; Murakami H; Kojima M; Nojima Y
Acta Haematol; 2009; 121(4):239-42. PubMed ID: 19556752
[No Abstract] [Full Text] [Related]
16. Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma: report of two cases with no evidence of systemic disease.
Szepesi Á; Csomor J; Rajnai H; Erős N; Wikonkál N; Kárpáti S; Matolcsy A; Marschalkó M
Eur J Dermatol; 2012; 22(5):690-1. PubMed ID: 22940730
[No Abstract] [Full Text] [Related]
17. Paraneoplastic cerebellar degeneration: initial presentation in a patient with anaplastic T-cell lymphoma, associated with ichthyosiform cutaneous lesions.
Rodis DG; Liatsos GD; Moulakakis A; Pirounaki M; Tasidou A
Leuk Lymphoma; 2009 Aug; 50(8):1369-71. PubMed ID: 19544138
[No Abstract] [Full Text] [Related]
18. [Standard and experimental therapy of cutaneous T-cell lymphoma].
Beyeler M; Dummer R
Hautarzt; 2003 Dec; 54(12):1177-84. PubMed ID: 14634747
[TBL] [Abstract][Full Text] [Related]
19. Extracutaneous tumour mass following bexarotene and interferon therapy of primary cutaneous CD30+ large cell lymphoma.
Kreuter A; Altmeyer P; Gambichler T
Acta Derm Venereol; 2006; 86(3):274-5. PubMed ID: 16710601
[No Abstract] [Full Text] [Related]
20. Syndrome of inappropriate antidiuretic hormone secretion associated with primary cutaneous anaplastic large cell lymphoma.
Hirata Y; Yokote T; Nishiwaki U; Tsuji M; Hanafusa T
Br J Haematol; 2012 May; 157(4):412. PubMed ID: 22409317
[No Abstract] [Full Text] [Related]
[Next] [New Search]
